SPARK THERAPEUTICS, INC. Financing Cash Flow
SPARK THERAPEUTICS, INC. reported Financing Cash Flow of -$1.06 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2019-11-07
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was -$1.02M, a 101.97% decline year-over-year.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was $3.18M, a 65.82% decline year-over-year.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-03-31 was -$3.22M, a 1335.25% decline year-over-year.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2018-12-31 was $1.76M, a 48.76% decline year-over-year.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2018 was $62.95M, a 84.27% decline from fiscal 2017.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2017 was $400.27M, a 204.70% increase from fiscal 2016.
- SPARK THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2016 was $131.37M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.16M derived: sum of 2 quarters · filed 2019-11-07 | -$1.06M 10-Q · filed 2019-11-07 | $697.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$46.00K 10-Q · filed 2019-08-08 | $1.71M derived: sum of 3 quarters · filed 2019-08-08 | $53.35M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | -$3.22M 10-Q · filed 2019-05-10 | -$1.46M derived: sum of 2 quarters · filed 2019-05-10 | $50.17M derived: sum of 3 quarters · filed 2019-11-07 | $59.47M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $53.39M derived: sum of 2 quarters · filed 2019-11-07 | $62.69M derived: sum of 3 quarters · filed 2019-11-07 | $62.95M 10-K · filed 2019-02-28 |
| 2018-09-30 | $51.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $60.93M derived: sum of 2 quarters · filed 2019-11-07 | $61.19M 10-Q · filed 2019-11-07 | $64.63M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $9.56M 10-Q · filed 2019-08-08 | $12.99M derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | $261.00K 10-Q · filed 2019-05-10 | $3.70M derived: sum of 2 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $400.27M 10-K · filed 2019-02-28 | ||
| 2017-09-30 | $396.84M 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $131.37M 10-K · filed 2019-02-28 |